Non- Insulin based diabetes therapies

Type 2 Diabetes, also known as adult-onset diabetes, is a type of diabetes characterised by high blood sugar, insulin resistance, and a relative lack of insulin. Symptoms may also include increased hunger, fatigue, and unhealed sores. Long-term complications of diabetes include heart disease, strokes, diabetic retinopathy (which can lead to blindness), kidney failure, and poor blood flow in the limbs, which can lead to amputations. The primary metabolic effect of this is to inhibit glucose reabsorption in the kidney, lowering blood sugar. They work by inhibiting the sodium-glucose transport protein 2 (SGTP2) (SGLT2). Type II diabetes mellitus is treated with SGLT2 inhibitors (T2DM).

  • Nutrition and diet
  • Oral therapies: metformin, sensitizers and other non-secretagogues
  • SGLT inhibitors
  • Incretin-based therapies
  • Novel agents

Related Conference of Non- Insulin based diabetes therapies

February 24-25, 2025

34th European Diabetes Congress

London, UK
March 10-11, 2025

4th Global Summit on Physiology and Metabolism of Thyroid

Singapore City, Singapore
March 17-18, 2025

5th European Endocrinology and Diabetes Congress

Paris, France
April 10-11, 2025

5th World Congress on Endocrine and Diabetes

Dubai, UAE
April 10-11, 2025

4th International Summit on Hormonal Disorders

Dubai, UAE
May 19-20, 2025

6th World Summit on Diabetes

Rome, Italy
June 04-05, 2025

4th World Congress on Diabetes and Pediatric Endocrinology

Edinburgh, Scotland
July 29-30, 2025

15th World Congress on Endocrinology and Diabetes

Aix-en-Provence, France
September 08-09, 2025

3rd World congress and Expo on Diabetes

Frankfurt, Germany
November 20-21, 2025

21st World Congress on Endocrinology & Diabetes

Aix-en-Provence, France

Non- Insulin based diabetes therapies Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in